Rationale for combined therapies in severe-to-critical COVID-19 patients
对重症至危重症 COVID-19 患者采用联合疗法的理由
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1232472
Gonzaga, Aitor; Andreu, Etelvina; Hernández-Blasco, Luis M; Meseguer, Rut; Al-Akioui-Sanz, Karima; Soria-Juan, Bárbara; Sanjuan-Gimenez, Jose Carlos; Ferreras, Cristina; Tejedo, Juan R; Lopez-Lluch, Guillermo; Goterris, Rosa; Maciá, Loreto; Sempere-Ortells, Jose M; Hmadcha, Abdelkrim; Borobia, Alberto; Vicario, Jose L; Bonora, Ana; Aguilar-Gallardo, Cristobal; Poveda, Jose L; Arbona, Cristina; Alenda, Cristina; Tarín, Fabian; Marco, Francisco M; Merino, Esperanza; Jaime, Francisco; Ferreres, José; Figueira, Juan Carlos; Cañada-Illana, Carlos; Querol, Sergio; Guerreiro, Manuel; Eguizabal, Cristina; Martín-Quirós, Alejandro; Robles-Marhuenda, Ángel; Pérez-Martínez, Antonio; Solano, Carlos; Soria, Bernat